InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.04
(
0.15%
)
Bitcoin
56,985.40
(
-5.28%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 84
Posts 12471
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: vidpok45 post# 556

Wednesday, 06/23/2010 7:25:44 AM

Wednesday, June 23, 2010 7:25:44 AM

Post# of 80490
Actually, the approval of Rida for Sarcoma will BE a big event. Mr. Market is pretty smart. There are many individuals on the sidelines that refuse to invest in an oncology company without a product, and are waiting for a go-no go on Rida. They have figured out that approval will open the door to $500 million in royalities, and milestone payments to Ariad. The present value of that cashflow stream is worth much, much more than booking sales. This will sew the seeds in creating an independent, standalone oncology company.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up